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Abstract
Rationale: Antibiotic stewardship has been defined as coordinated interventions designed to
improve and measure the appropriate use of antibiotic agents. Respiratory infections are the most
common infectious reason for hospitalization in the United States. Therefore, one could extrapolate
that respiratory infections are then also the most common reason for hospital antibiotic use and
possess the highest potential for hospital antibiotic misuse. The primary objective of this article was
to evaluate the role of antimicrobial stewardship on improving antibiotic use for respiratory infections
in hospitalized patients on intravenous (IV) antibiotics at the Robley Rex Louisville VAMC over a 10year period.
Methods: This was a retrospective review of the Robley Rex Louisville VAMC ASP Switch Therapy
and Antimicrobial Review database. The study included all Robley Rex Louisville VAMC patients
admitted to the hospital and placed on IV antibiotics between January 1st 2007 and December 31st
2016.
Results: Recommendations from an antimicrobial stewardship team (AST) improve hospital IV
antibiotic use in respiratory infections to a level above 90%.
Conclusion: AST recommendations regarding antibiotic use for respiratory infections improve
compliance with hospital guidelines. There is an ongoing role for antimicrobial stewardship programs
overtime.
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Introduction
Antibiotic stewardship has been defined as coordinated
interventions designed to improve and measure the appropriate
use of antibiotic agents. This is accomplished by promoting
the selection of the optimal antibiotic drug regimen including
dosing, duration of therapy, and route of administration [1].
Successful implementation of antimicrobial stewardship
programs has been associated with several benefits. These
include improved patient outcomes, reduced adverse events
including Clostridium difficile infection (CDI), decreased
antibiotic resistance, and resource optimization such as
decreased length of stay and cost of care. As a result of this, The
Joint Commission, a United States not-for-profit organization
dedicated to improving quality and effectiveness in healthcare,
now requires an antimicrobial stewardship program (ASP) for
hospital accreditation and certification. Additionally, in 2016,
The Infectious Disease Society of America (IDSA) released
national guidelines on implementing an ASP [2].
Respiratory infections are the most common infectious reason
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for hospitalization in the United States [3]. Therefore, one could
extrapolate that respiratory infections are then also the most
common reason for hospital antibiotic use and possess the
highest potential for hospital antibiotic misuse. To address this
concern, as well as antibiotic misuse as a whole, a program to
improve antibiotic use was created at the Robley Rex Louisville
VA Medical Center (VAMC) in 1990 [4]. The antimicrobial
stewardship team (AST) was formed as part of the ASP, and
members included infectious diseases pharmacists, infectious
disease physicians, and a microbiologist. Hospital guidelines for
the management of different infections were created by the AST
and monthly reports were generated detailing hospital antibiotic
use. In general, hospital guidelines reflect the implementation
of national guidelines at the local level. Antibiotic use was
determined to be either complaint or non-compliant with
hospital guidelines. If antibiotic use was found to be compliant
with hospital guidelines, no antibiotic recommendations were
made. If antibiotic use was determined to be non-complaint with
hospital guidelines, recommendations were made by the AST in
the medical record. In the instances where recommendations
were made, we then tracked if the recommendations were
accepted or not accepted. To generate these reports a program
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was developed in Microsoft Access and entitled Switch Therapy
and Antimicrobial Review [5].

antibiotics upon or during a hospital admission. Each inpatient
infection requiring IV antibiotics represented a case.

The primary objective of this article was to evaluate the role
of antimicrobial stewardship on improving antibiotic use for
respiratory infections in hospitalized patients on intravenous
(IV) antibiotics at the Robley Rex Louisville VAMC over a 10year period. The secondary objectives included describing the
most common 1) types of infections, 2) pathogens associated
with respiratory infections, and 3) IV antibiotics used for
respiratory infections with respective compliance with hospital
guidelines before and after recommendations over the same 10year period.

Antibiotic courses were defined by each individual IV antibiotic
regimen a patient received during a particular infectious case.
A single infectious case may have received numerous antibiotic
courses.

Materials and Methods
This was a retrospective review of the Robley Rex Louisville
VAMC ASP Switch Therapy and Antimicrobial Review database.
The study included all Robley Rex Louisville VAMC patients
admitted to the hospital and placed on IV antibiotics between
January 1st 2007 and December 31st 2016. This study was
approved by the Robley Rex Louisville VAMC and informed
consent was waived (IRB ID: 00049 Prom#: 0061). Data on
each patient was collected by the antimicrobial stewardship
pharmacist after they were alerted that the patient was
receiving IV antibiotic treatment. The data collection included
the following 15 variables; patient age, gender, admit date,
discharge date, onset date and where infection was acquired,
diagnosis, antibiotic name as well as antibiotic start and
stop date, antibiotic indication and dose, culture results, and
annotation indicating if antibiotic therapy was pathogendirected or empiric and whether or not a patient was a candidate
for oral switch therapy. This information was then used to
evaluate antibiotic use.
The AST pharmacist gave real time feedback on intravenous
antimicrobial orders and evaluated the compliance with local
hospital antimicrobial guidelines. Areas of compliance that were
reviewed consisted of the following; evaluation of the initial
empiric regimen for appropriateness of spectrum of coverage,
appropriateness of dose based on diagnosis, and potential
for use of a less toxic antimicrobial agent. Continued review
occurred throughout the patient’s hospitalization following the
initial evaluation and was based on clinical response and culture
results with an evaluation of length of therapy and possibility
for de-escalation of the empiric regimen. Prospective audit
and feedback occurred with recommendations from the AST
documented in the patient electronic record and in some cases
through additional phone call or face to face discussion with the
prescriber.
Study Definitions
Respiratory infections in this study were classified at the time
of diagnosis in the database as either community-acquired
pneumonia (CAP), healthcare-associated pneumonia (HCAP),
hospital-acquired pneumonia (HAP), ventilator-associated
pneumonia (VAP), acute exacerbation of chronic obstructive
pulmonary disease (AECOPD), empyema, or lung abscess.
The type of respiratory infection was defined by the primary
physician’s diagnosis as documented in the patient’s record.

The following 4 criteria were used to define when a patient
should be considered a candidate for oral switch therapy:
[1] cough and shortness of breath improving, [2] afebrile
(temperature, <37.8°C) for at least 8 hours, [3] white blood
cell count normalizing, and [4] adequate oral intake and
gastrointestinal tract absorption. A patient who was able to take
food by mouth without evidence of diarrhea or malnutrition was
considered to have adequate oral intake and gastrointestinal
tract absorption.
Antibiotic compliance was assessed daily during admission
regarding appropriateness of empiric or pathogen directed
therapy, dosing, and duration.
Statistical Analysis
Descriptive statistics were performed. Data was reported as
frequencies (n) and percentages (%). The percent compliance
before and after AST recommendation was calculated by
dividing the total number of compliant evaluations and the total
number of compliant opportunities. Line graphs were produced
to display changes in compliance over time. Statistical analysis
was performed with R version 3.3.2 [6].

Results
Antibiotic compliance with hospital guidelines before and after
the AST recommendations are demonstrated by year for the
most prominent respiratory infections including CAP, HCAP,
HAP, as well as all respiratory infections combined in Figures
1-4.

Fig. 1. Antibiotic compliance with hospital guidelines for communityacquired pneumonia before and after antimicrobial stewardship team
(AST) recommendations.

Infectious cases were defined as an infection requiring IV
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A total of 18,932 IV antibiotic courses were reviewed by the
AST at the Robley Rex Louisville VAMC during the 10-year
time period. This was representative of 5,928 infectous cases.
Respiratory infections accounted for 6,882IV antibiotic courses
used in 2,133 infectious. The total of IV antibiotic courses and
infectious cases reviewed by the AST for respiratory infections
are listed by infection type in Table 1.

Table 1. Respiratory Infections and Antibiotic Courses
Diagnosis

Infections (n=2,133)

CAP
HCAP
HAP
AECOPD
Empyema
VAP
Lung Abscess

Fig. 2. Antibiotic compliance with hospital guidelines for healthcareassociated pneumonia before and after antimicrobial stewardship team

Antibiotic Courses (n=6,882)
778 (36)
580 (27)
465 (22)
186 (9)
69 (3)
50 (2)
5 (0)

2143 (31)
2092 (30)
1771 (26)
280 (4)
374 (5)
208 (3)
14 (0)

CAP: community-acquired pneumonia; HCAP: healthcare-associated pneumonia; HAP: hospitalacquired pneumonia; AECOPD: acute exacerbation of chronic obstructive pulmonary disease; VAP:
ventilator-associated pneumonia

(AST) recommendations.

The complete list of IV antibiotic courses and infectious cases
reviewed by the AST for all other types of infections are listed by
infection type in Table 2.

Table 2. Other Infections and Antibiotic Courses

Fig. 3. Antibiotic compliance with hospital guidelines for hospitalacquired pneumonia before and after antimicrobial stewardship team
(AST) recommendations.

Diagnosis
Bone and Joint Infections
Osteomyelitis
Septic Joint
Central Nervous System Infections
Meningitis
Encephalitis
Syphilis
Brain Abscess
Ventriculoperitoneal Shunt Infection
Endovascular Infections
Intravenous Catheter Infection
Endocarditis
Vascular graft
Intra-abdominal Infections
Peritonitis
Cholecystitis
Intra-abdominal Abscess
C. diﬃcile Colitis
Diverticulitis
Pancreatitis
Skin and Soft Tissue Infections
Cellulitis
Surgical Wound Infection
Diabetic Foot Infection
Perirectal Abscess
Necrotizing fasciitis
Myonecrosis
Urinary Tract Infections
Pyelonephritis
Cystitis
Other Infections

Infections

517 (14)
453 (88)
64 (12)
63 (2)
50 (79)
9 (14)
2 (3)
1 (2)
1 (2)
293 (8)
153 (52)
108 (37)
32 (11)
508 (13)
148 (29)
116 (23)
97 (19)
89 (18)
38 (7)
20 (4)
706 (19)
540 (76)
72 (10)
54 (8)
24 (3)
13 (2)
3 (0)
971 (26)
713 (73)
258 (27)
737 (19)

Antibiotic Courses
2475 (21)
2285 (92)
190 (8)
189 (2)
151 (80)
26 (14)
2 (1)
4 (2)
6 (3)
1213 (10)
585 (48)
428 (35)
200 (16)
1393 (12)
478 (34)
253 (18)
375 (27)
138 (10)
93 (7)
56 (4)
2238 (19)
1587 (71)
236 (11)
223 (10)
55 (2)
118 (5)
19 (1)
2209 (18)
1853 (84)
356 (16)
2333 (19)

The most common respiratory pathogens identified in our
hospital are listed in Table 3.

Table 3. Most Frequent Organisms by Type of Pneumonia

Fig. 4. Antibiotic compliance with hospital guidelines for all respiratory
infections before and after antimicrobial stewardship team (AST)
recommendations.

CAP
S. pneumonia
H. inﬂuenzae
MSSA
MRSA
Pseudomonas
Streptococcus other
Klebsiella
E. coli
Moraxella

n (%)
73 (27)
32 (12)
31 (11)
24 (9)
18 (7)
16 (6)
13 (5)
9 (3)
6 (2)

HAP
MRSA†
Pseudomonas
Klebsiella
Enterobacter
E. coli
MSSA‡
H. inﬂuenzae
S. pneumoniae
Acinetobacter

n (%)
85 (28)
40 (13)
33 (11)
21 (7)
18 (6)
18 (6)
15 (5)
10 (3)
6 (2)

HCAP
MRSA†
Pseudomonas
MSSA‡
S. pneumoniae
E. coli
H. inﬂuenzae
Proteus
Klebsiella
Enterobacter

n (%)
77 (27)
45 (16)
33 (11)
25 (9)
24 (8)
13 (4)
12 (4)
11 (4)
8 (3)

†MSSA: methicillin-susceptible Staphylococcus aureus; ‡MRSA: methicillin-resistant Staphylococcus
aureus
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The most frequently used IV antibiotics for respiratory infections
in our hospital as well as compliance with hospital guidelines
before and after recommendations are listed in Table 4.
Table 4. Most frequently used antibiotics for respiratory infections with
respective compliance with hospital guidelines.
Antibiotic Given
Ceftriaxone
Moxiﬂoxacin
Azithromycin
Vancomycin
Levoﬂoxacin
Piperacillin/Tazobactam
Clindamycin
Ampicillin/Sulbactam
Cefepime
Ciproﬂoxacin
Antibiotic Given
Vancomycin
Piperacillin/Tazobactam
Levoﬂoxacin
Ciproﬂoxacin
Cefepime
Meropenem
Imipenem/Cilastin
Linezolid
Moxiﬂoxacin
Ceftriaxone
Antibiotic Given
Vancomycin
Piperacillin/Tazobactam
Levoﬂoxacin
Cefepime
Meropenem
Moxiﬂoxacin
Ceftriaxone
Ciproﬂoxacin
Azithromycin
Imipenem/Cilastin

Community Acquired Pneumonia
n (%)
Compliance Before† Compliance After †
428 (21)
91
98
300 (15)
83
97
272 (13)
89
99
272 (13)
63
91
240 (21)
79
96
146 (7)
53
80
57 (3)
75
91
53(3)
93
96
39 (2)
77
97
29 (1)
72
97
Hospital Acquired Pneumonia
†
†
n (%)
Compliance Before
Compliance After
468 (26)
77
95
368 (21)
81
97
157 (9)
76
94
108 (6)
77
95
93 (5)
88
99
89 (5)
83
92
78 (4)
74
95
73 (4)
85
97
41 (2)
63
95
38 (2)
50
87
Healthcare Associated Pneumonia
n (%)
Compliance Before† Compliance After †
653 (31)
77
96
431 (21)
83
98
335 (16)
81
95
106 (5)
86
99
87 (4)
83
95
80 (4)
81
99
71 (3)
80
99
50 (2)
78
100
45 (2)
89
96
38 (2)
61
97

†Percent compliance

Reasons for non-compliance by our evaluation included
inappropriate empiric or pathogen directed antimicrobial
therapy regarding agent, dose, duration, or toxicity.

Discussion
The results of this study demonstrate that recommendations
from an AST regarding antibiotic use for respiratory infections
improve compliance with hospital guidelines. This is consistent
with other studies that have demonstrated improvement in
antibiotic use after intervention from an ASP for other types of
infection such as skin and soft tissue infections [7,8]. However,
while our study demonstrated improved compliance with
hospital guidelines after AST recommendations each year, the
data did not demonstrate an overall improvement in antibiotic
use before recommendations over time as one may expect with
continuous audit and feedback. This is can be explained by the
fact that our institution is a teaching hospital. Residents rotate
through regulary providing an essentially continual influx of
new learners.
Lack of improvement in antibiotic use over time prior to
guideline based recommendations, highlights the importance
of and role for an ongoing antimicrobial stewardship presence.
This suggests that not only developing guidelines but forming
and supporting an AST to assist with implementation of the
guidelines on a local level is essential. Local implemenation
of national guidelines is an area that has been shown to need
improvement [9]. Our study suggests that an AST may help to
bridge that gap.

Going forward, in the absence of uniform national guidelines,
the creation of locally based hospital guidelines for a particular
infection type via an ASP may further promote appropriate
antibiotic use where it would otherwise be lacking. For example,
at the Robley Rex Louisville VAMC we are developing local
guidelines for hospitalized patients with COPD exacerbations, a
common reason for hospitalization for which national guidelines
are not yet established.
Lastly, our study reinforced that respiratory infections are
a common reason for hospitalization and administration of
IV antibiotics. In fact, our results demonstrated that overall,
respiratory infections were the most common reason for
hospitalization requiring IV antibiotics at the Robley Rex
Louisville VAMC. As one might expect, the most common
etiology for CAP was Streptococcus pneumoniae, and the
most common pathogens causing healthcare-associated
respiratory tract infections included MRSA and Pseudomonas
aeruginosa. This exemplifies the reason for differing guideline
recommendations regarding empiric therapy for respiratory
infections depending on the type of infection and patient
risk factors. Illustrating the effectiveness of antimicrobial
stewarship, the most commonly used IV antibiotics for those
infections in this study were appropriate.
This study had several limitations including that is was a
retrospective review with no utcome data. Without outcome
data it is impossible to say that improved antibiotic use was
associated with improved patient outcomes. Also, because this
study took place in a teaching hospital we cannot assume that
the results are generalizable to all inpatient hospital settings.
In conclusion, there is an ongoing role for ASP’s and antibiotic
guidance over time as it does appear to improve antibiotic
use. Following national trends, the most common reasons
for hospitalization requiring IV antibiotics were respiratoryassociated infections.
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